COVID-19 como factor de riesgo para preeclampsia con signos de severidad. Hospital Regional Docente de Trujillo. Periodo 2021-2022
No Thumbnail Available
Date
2023-06-28
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Nacional de Trujillo
Abstract
La enfermedad por COVID-19 es una pandemia global, que filogenéticamente está estrechamente relacionado con SARS-CoV. Inició en diciembre del 2019 en Wuhan, en China y fue declarada pandemia global en marzo del 2020.La sintomatología común incluye fiebre y tos.
La preeclampsia se considera un síndrome multisistémico que complica aproximadamente al 5 % de los embarazos y un problema de salud importante ya que según la OMS es la segunda causa de muerte materna en el mundo pues representa aproximadamente el 14 % y en el año 2018 resultó ser la primer causa de muerte materna con 28 %.
La prevalencia por COVID-19 en embarazadas es de 5% a 14%, similar a la de la población general. Sin embargo, la Organización Panamericana de la Salud y la OMS indican que estas pacientes están en mayor riesgo de presentar una forma grave de la enfermedad y, en algunos casos, ocasionarles la muerte.
Como justificación práctica, es necesario estudiar la relación entre COVID 19 y preeclampsia por ser enfermedades frecuentes a nivel mundial y que afectan en gran medida a la población materna. La posibilidad de que las gestantes con infección por SARS Cov 2 tienen mayores posibilidades de desarrollar preeclampsia hará que los profesionales de la salud realicen una monitorización más estricta para la detección temprana de preeclampsia y así evitar consecuencias que afecten al binomio madre - hijo.
Abstract The COVID-19 disease is a global pandemic, which is phylogenetically closely related to SARS-CoV. It began in December 2019 in Wuhan, China and was declared a global pandemic in March 2020. Common symptoms include fever and cough. Preeclampsia is considered a multisystem syndrome that complicates approximately 5% of pregnancies and an important health problem since, according to the WHO, it is the second cause of maternal death in the world, representing approximately 14% and in 2018 it turned out to be the first cause of maternal death with 28%. The prevalence of COVID-19 in pregnant women is 5% to 14%, similar to that of the general population. However, the Pan American Health Organization and the WHO indicate that these patients are at greater risk of presenting a severe form of the disease and, in some cases, causing death. As a practical justification, it is necessary to study the relationship between COVID 19 and preeclampsia because they are common diseases worldwide and greatly affect the maternal population. The possibility that pregnant women with SARS Cov 2 infection have a greater chance of developing preeclampsia will make health professionals carry out stricter monitoring for the early detection of preeclampsia and thus avoid consequences that affect the mother-child binomial.
Abstract The COVID-19 disease is a global pandemic, which is phylogenetically closely related to SARS-CoV. It began in December 2019 in Wuhan, China and was declared a global pandemic in March 2020. Common symptoms include fever and cough. Preeclampsia is considered a multisystem syndrome that complicates approximately 5% of pregnancies and an important health problem since, according to the WHO, it is the second cause of maternal death in the world, representing approximately 14% and in 2018 it turned out to be the first cause of maternal death with 28%. The prevalence of COVID-19 in pregnant women is 5% to 14%, similar to that of the general population. However, the Pan American Health Organization and the WHO indicate that these patients are at greater risk of presenting a severe form of the disease and, in some cases, causing death. As a practical justification, it is necessary to study the relationship between COVID 19 and preeclampsia because they are common diseases worldwide and greatly affect the maternal population. The possibility that pregnant women with SARS Cov 2 infection have a greater chance of developing preeclampsia will make health professionals carry out stricter monitoring for the early detection of preeclampsia and thus avoid consequences that affect the mother-child binomial.
Description
Keywords
COVID-19, Preeclampsia, Infección por SARS-CoV-2, Enfermedad del Coronavirus-19